Ophthopedia shares a published reply to a large retrospective study in Ophthalmology Retina comparing eye outcomes in type 2 diabetes patients.
Recap by typeshit. Post by Facebook on Facebook.
Among 208,970 matched adults with type 2 diabetes, GLP-1 starters had 0.15% new diagnoses versus 0.10% on DPP-4 drugs. Authors call it a signal needing confirmation.
Researchers used AI to identify fungal peptides that taste salty or boost saltiness, aimed at cutting sodium in food. A food science find rather than a drug story.
The 1,200-person trial starts next year with MIT and Pitt researchers, funded by a $13 million Arnold Ventures grant, and will also track housing and jobs.
Researchers found the peptide they built as a treatment already circulates in human blood, at lower levels in people with cognitive impairment.
A new episode of the Annals of Internal Medicine podcast looks at tirzepatide in type 2 diabetes treatment. Listen through for the full discussion.
A new Annals of Internal Medicine podcast episode has Dr. Centor discussing where tirzepatide fits in type 2 diabetes treatment.
Loading…